CCL21 and type 2 diabetes mellitus: These findings suggest that CCL21 mRNA in urinary sEVs could potentially serve as a more effective biomarker for the early detection of DN in patients with type 2 diabetes mellitus (T2DM), offering advantages over traditional measures such as eGFR and proteinuria levels (Feng et al., 2021).